Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:05 AM
Study NCT ID:
NCT04415918
Status:
UNKNOWN
Last Update Posted:
2020-06-04
First Post:
2020-06-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bezlotoxumab Efficacy and Tolerability in Cancer Patient
Sponsor:
The Cooper Health System
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-01
First Submit QC Date:
None
Study First Post Date:
2020-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-01
Last Update Post Date:
2020-06-04
Last Update Post Date Type:
ACTUAL